N4-Chloroacetylcytosine arabinoside

N4-Chloroacetylcytosine arabinoside (also known as N4-CCA) is a chemical compound that belongs to the class of nucleoside analogues. It is a derivative of cytosine arabinoside, a medication used in the treatment of various types of cancer.

Chemistry

N4-Chloroacetylcytosine arabinoside is a synthetic compound that consists of a cytosine base attached to an arabinose sugar molecule. The cytosine base is modified by the addition of a chloroacetyl group at the N4 position. This modification enhances the compound's ability to inhibit DNA synthesis, making it a potential candidate for use in chemotherapy.

Pharmacology

The pharmacological action of N4-Chloroacetylcytosine arabinoside is similar to that of other nucleoside analogues. It is incorporated into the DNA of rapidly dividing cells, such as cancer cells, where it inhibits DNA synthesis and induces cell death. However, the exact mechanism of action of N4-CCA is still under investigation.

Clinical Use

While N4-Chloroacetylcytosine arabinoside is not currently approved for use in humans, it has shown promise in preclinical studies for the treatment of various types of cancer, including leukemia and lymphoma. Further research is needed to determine its safety and efficacy in humans.

See Also

• Cytosine arabinoside
• Nucleoside analogue
• Chemotherapy

‎

‎ ‎

---

Translate: - East Asian 中文, 日本, 한국어, South Asian हिन्दी, தமிழ், తెలుగు, Urdu, ಕನ್ನಡ, Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, বাংলা
European español, Deutsch, français, Greek, português do Brasil, polski, română, русский, Nederlands, norsk, svenska, suomi, Italian
Middle Eastern & African عربى, Turkish, Persian, Hebrew, Afrikaans, isiZulu, Kiswahili,
Other Bulgarian, Hungarian, Czech, Swedish, മലയാളം, मराठी, ਪੰਜਾਬੀ, ગુજરાતી, Portuguese, Ukrainian